Methods of preparing cytotoxic benzodiazepine derivatives

US2021230114A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2021230114-A1
Application numberUS-202117143723-A
CountryUS
Kind codeA1
Filing dateJan 7, 2021
Priority dateNov 12, 2018
Publication dateJul 29, 2021
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.

First claim

Opening claim text (preview).

1 - 32 . (canceled) 33 . A method of preparing a compound of formula (III): or a salt thereof, comprising the steps: (a) reacting a compound of formula (I): or a salt thereof, with a compound of formula (a): or a salt thereof, to form a compound of formula (II): and (b) reacting the compound of formula (II) with a carboxylic acid deprotecting agent to form the compound of formula (III), wherein E is —OH, halide or —C(═O)E is an activated ester; and P 1 is a carboxylic acid protecting group. 34 . The method of claim 33 , wherein the method further comprises reacting the compound of formula (III) with a compound of formula (IV): to form a compound of formula (V): 35 . The method of claim 33 , wherein P 1 is —O t Bu, —OMe, —OBn, or —O-silyl. 36 . The method of claim 35 , wherein P 1 is —O t Bu. 37 . The method of claim 33 , wherein E is —OH and the reaction between the compound of formula (I) and the compound of formula (a) is carried out in the presence of an activating agent. 38 . The method of claim 37 , wherein the activating agent is a 2,4,6-trialkyl-1,3,5,2,4,6-trioxatriphosphorinane 2,4,6-trioxide, carbodiimide, a uronium, an activated ester, a phosphonium, 2-alkyl-1-alkylcarbonyl-1,2-dihydroquinoline, 2-alkoxy-1-alkoxycarbonyl-1,2-dihydroquinoline, or alkylchloroformate. 39 . The method of claim 38 , wherein the activating agent is 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide. 40 . The method of claim 33 , wherein the carboxylic acid deprotecting agent in step (b) is an acid. 41 . The method of claim 40 , wherein the acid is trifluoroacetic acid (TFA). 42 . The method of claim 33 , wherein E, when present, is —OH and the reaction in step (a) is carried out in the presence of an activating agent that is HATU and HOAt. 43 . A method of preparing a compound of formula (V): comprising the steps of: (a) reacting a compound of formula (I): or a salt thereof, with a compound of formula (a): or a salt thereof, to form a compound of formula (II): (b) reacting the compound of formula (II) with a carboxylic acid deprotecting agent to form the compound of formula (III): or a salt thereof; and (c) reacting the compound of formula (III) with a compound of formula (IV): to form the compound of formula (V), wherein E is —OH, halide or —C(═O)E that is an activated ester; and P 1 is a carboxylic acid protecting group. 44 . The method of claim 43 , wherein P 1 is —O t Bu, —OMe, —OBn, or —O-silyl. 45 . The method of claim 44 , wherein P 1 is —O t Bu. 46 . The method of claim 43 , wherein E is —OH and the reaction between the compound of formula (I) and the compound of formula (a) is carried out in the presence of an activating agent. 47 . The method of claim 46 , wherein the activating agent is a 2,4,6-trialkyl-1,3,5,2,4,6-trioxatriphosphorinane 2,4,6-trioxide, carbodiimide, a uronium, an activated ester, a phosphonium, 2-alkyl-1-alkylcarbonyl-1,2-dihydroquinoline, 2-alkoxy-1-alkoxycarbonyl-1,2-dihydroquinoline, or alkylchloroformate. 48 . The method of claim 47 , wherein the activating agent is 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide. 49 . The method of claim 43 , wherein the carboxylic acid deprotecting agent in step (b) is an acid. 50 . The method of claim 49 , wherein the acid is trifluoroacetic acid (TFA).

Assignees

Inventors

Classifications

  • Ortho-condensed systems · CPC title

  • having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide · CPC title

  • with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom · CPC title

  • with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide · CPC title

  • Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2021230114A1 cover?
The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
Who is the assignee on this patent?
Immunogen Inc
What technology area does this patent fall under?
Primary CPC classification C07D207/452. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jul 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).